AACC's Go-To Conclave for Networking, Research, Technology
|
By CLN Stat Posted on 29 Jul 2019 |
(Photo courtesy of AACC)
The 71st AACC Annual Scientific Meeting & Clinical Lab Expo offers something for everyone in clinical laboratory medicine, showcasing the latest in precision medicine, novel biomarker research, the opioid epidemic and journals hot topics, plus a host of networking events and technology game-changers at the Expo.
Janetta Bryksin, PhD, DABCC, co-director of clinical chemistry and director of special chemistry at Emory Healthcare in Atlanta, is among the many enthusiastic AACC members who plan to attend this year’s meeting in Anaheim, California. “If there is one conference to go to each year, it’ll be the AACC Annual Scientific Meeting for me,” Bryksin told CLN Stat. “It offers many learning and networking opportunities through scientific sessions, Expo presenters, and local section and division meetings, as well as informal mixer meetings.”
Joshua Akin, clinical laboratory scientist at UC San Diego Health System Center for Advanced Laboratory Medicine, is another AACC member gearing up for the ASM. “It’s a great opportunity to brush up on recent research and new technology, as well as current trends and emerging issues in clinical labs,” Akin said.
Bryksin and Akin neatly sum up the top five reasons for attending this yearly conclave:
The 71st AACC Annual Scientific Meeting & Clinical Lab Expo takes place on August 4–8 in Anaheim, California. AACC members receive a discount on registration. Come join the conclave in sunny Southern California to network and learn about the latest breakthroughs in laboratory scientists from world-renowned speakers.
Janetta Bryksin, PhD, DABCC, co-director of clinical chemistry and director of special chemistry at Emory Healthcare in Atlanta, is among the many enthusiastic AACC members who plan to attend this year’s meeting in Anaheim, California. “If there is one conference to go to each year, it’ll be the AACC Annual Scientific Meeting for me,” Bryksin told CLN Stat. “It offers many learning and networking opportunities through scientific sessions, Expo presenters, and local section and division meetings, as well as informal mixer meetings.”
Joshua Akin, clinical laboratory scientist at UC San Diego Health System Center for Advanced Laboratory Medicine, is another AACC member gearing up for the ASM. “It’s a great opportunity to brush up on recent research and new technology, as well as current trends and emerging issues in clinical labs,” Akin said.
Bryksin and Akin neatly sum up the top five reasons for attending this yearly conclave:
- 5 Plenary Sessions: Clinical genomics, biomarker discoveries, and extreme molecular diagnostics are among the cutting-edge topics being presented by world-class researchers. Another fascinating session will explore translating gene-disease associations to brain circuitry.
- 4(0)+ Special Events and Socials: Participants have 40 events to choose from, including education on shared interest topics and mixers hosted by AACC groups and divisions. For the last few years, the Society for Young Clinical Laboratorians (SYCL) workshops have been the highlight of Bryksin’s Annual Scientific Meeting experience. “SYCL workshops are always very engaging, educational, and fun! I’m looking forward to learning about the impact of technology utilization in laboratory medicine at the SYCL workshop this year,” she said.
Workshops and networking events create long-lasting memories for attendees. Akin fondly recalls a local AACC section networking event at the 2018 Annual Scientific Meeting in San Diego. Participants met at Petco Park and “ate hot dogs, caught up with old colleagues, and watched the San Diego Padres beat the Pittsburgh Pirates,” he recalled. - 3 Days of the Clinical Lab Expo: There’s no better resource for cutting-edge laboratory technology than the Clinical Lab Expo. With more than 850 exhibiting companies and 200 new product introductions, this event rightly claims the title as the world’s largest exposition for clinical laboratory products and services. Visiting the Expo for the first time, “it was so vastly, overwhelmingly huge with thousands of people all discussing the latest technologies, I didn’t know where to start!” said Alec Saitman, PhD, DABCC (CC, TC), director of toxicology and special chemistry at Providence Regional Laboratories in Portland, Oregon. Saitman not only will be attending this year’s Annual Scientific Meeting but also actively participating, as a SYCL workshop instructor and as a member of the CLN Daily editorial board, covering the meeting for the event’s official publication.
- 2(0,000) Lab Medicine Attendees: There’s no better place for a clinical lab professional to make connections with more than 20,000 expected for this year’s meeting. “I always enjoy chatting with vendors and laboratory professionals from all different walks of laboratory medicine,” said Akin.
- 1 Disruptive Tech Award Winner: AACC’s Disruptive Technology Award recognizes innovative testing solutions that improve patient care through diagnostic performance or access to high-quality testing. Developers of precision and personalized medicine diagnostics headline this year’s award. Three finalist teams will present data on their technologies and one team will walk away with a cash prize.
The 71st AACC Annual Scientific Meeting & Clinical Lab Expo takes place on August 4–8 in Anaheim, California. AACC members receive a discount on registration. Come join the conclave in sunny Southern California to network and learn about the latest breakthroughs in laboratory scientists from world-renowned speakers.
Latest AACC 2019 News
- Instrumentation Laboratory Presents New IVD Testing System
- Quidel Welcomes Newest Member of Triage Family
- ERBA Mannheim Unveils Next-Generation Automation
- Roche Demonstrates How Health Networks Are Driving Change in Labs and Beyond
- BioMérieux Spotlights Diagnostic Solutions in Use of Antibiotics
- Thermo Shows New Clinical Innovations
- Randox Launches New Innovations
- Streck Introduces Three New Antibiotic Resistance Detection Kits
- EKF Diagnostics Highlights Assay for Diabetes Patient Monitoring
- Sysmex America Exhibits New Products, Automation and Quality Solutions
- BBI Solutions Showcases Mobile Solutions Capabilities at AACC 2019
- MedTest Dx Releases New Product Line for Drugs of Abuse Testing
- Mesa Biotech Launches Molecular Test System at AACC 2019
- Ortho Clinical Diagnostics Highlights Groundbreaking Lab Technology
- Abbott Diagnostics Exhibits POC Diagnostics Solutions at AACC
- Beckman Coulter Demonstrates Latest Innovations in Lab Medicine
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more








